Novel Coronavirus (COVID-19) Resources and Special Communications

The AHA will host a call on Monday, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.

With the COVID-19 pandemic reaching the point in which vaccines against the coronavirus may soon be publicly available, the AHA is helping hospitals and health systems prepare for their arrival, while promoting public confidence in Food and Drug Administration-approved SARS-CoV-2 vaccines.

In a study of 106,543 patients hospitalized for COVID-19 between March and July, 9% were readmitted to the same hospital

The America Hospital Association (AHA) will host a webinar Nov. 19 at 1 p.m. ET with senior health care leaders

The Veterans Health Administration (VHA) recently released a report detailing the organization’s efforts to respond to the COVID-19 pandemic

Eligible family members of front-line health care workers and volunteers who lose their lives to COVID-19 can apply to the Brave of Heart Fund

Strategies and tools to address burnout as health care professionals continue to care for COVID-19 patients

This week, the National Academies of Sciences, Engineering, and Medicine (NASEM) released a report examining the advantages

Last week, the Food and Drug Administration (FDA) issued an emergency use authorization (EAU) for the first serology test

Operation Warp Speed released a playbook to assist providers in planning to allocate COVID-19 therapeutics.

This is a set of resources to help hospitals and health systems reassure staff, patients and communities of COVID-19 vaccines’ safety and effectiveness. It includes messaging for many important audiences, whether organizational (stakeholders inside hospitals or health systems) or public-facing (patients and communities).

A website launched during the pandemic provides reliable resources for people to manage their mental health and seek help for loved ones and themselves when needed.

A program at UAMS Health in Arkansas pairs medical residents, fellows and students with older adult patients for virtual social visits.

The Food and Drug Administration Nov. 10 issued an emergency use authorization (EUA) for Eli Lilly and Company’s monoclonal antibody therapy, bamlanivimab. The EUA authorizes the product’s use, but only in outpatient settings; additionally, it sets forth the type of patients eligible to receive the treatment, the drug’s storage requirements and a brief overview of how distribution will work.

Join M. Bridget Duffy, M.D., chief medical officer of Vocera Communications Inc., for a SHSMD webinar featuring an important discussion about the benefits of embracing human-centered leadership. Duffy is the subject matter expert for the article Frictionless Health Care Requires a Connected Healing Ecosystem in the society’s Futurescan 2020 publication highlighting important trends in health care. She will be joined in the webinar by Liz Boehm, executive strategist, human-centered research at the Experience Innovation Network.